logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

USD Bond Movement | Shimao Group SHIMAO 2 07/21/32 price fell 57.45% to 0.520.

date
16/09/2026
On September 16, SHIMAO 2 07/21/32 issued by Shimao Group was priced at 0.520, down -57.450%, with a yield of 104.336%.
Latest
1 m ago
SSY Group (02005.HK) repurchased 850,000 shares for HK$2.304 million on September 16.
3 m ago
Fibocom (00638.HK) repurchased 682,800 A shares for RMB 7.0482 million on September 16.
4 m ago
Sanofi (SNY.O) unveiled its Shanghai Foreign-Funded R&D Innovation Center, and signed a cooperation agreement with Huashan Hospital Affiliated to Fudan University for a "Center of Excellence in Translational Research." In 2025, Sanofi's revenue reached 46.7 billion euros, with China being Sanofi's second-largest market globally. According to the plan, the center will become Sanofi's largest translational medicine research center in China, bringing together global R&D forces to advance innovative drug development in key areas such as immunology, chronic diseases, oncology, and rare diseases. (Yicai)
8 m ago
SBT Ultrasonic Technology (688392.SH)'s application for issuing A-shares to specific targets received approval for registration from the CSRC.
10 m ago
Deye Co., Ltd. (605117.SH) plans to repurchase company shares for RMB 100 million to RMB 200 million.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.